GlassScriptPhysician profile
Eric A Gershenbaum
NPI 1548227309
$22,687.33
in general payments reported to CMS, 2019-2025
30 companies · $2,610 in 2025
The $2,610 reported for 2025 was more than what 90% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,612 · 2020: $1,337 · 2021: $3,380 · 2022: $5,968 · 2023: $3,857 · 2024: $3,924 · 2025: $2,610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,375 · Travel and Lodging: $1,682 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,375.27 |
| Travel and Lodging | $1,681.61 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $333.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $5,981.30 | 2019-2025 | Catalys System, Tecnis Iol, Tecnis Iol |
| Glaukos Corporation | $2,784.45 | 2019-2025 | Idosetr, Istent, Idose |
| Sight Sciences, INC. | $2,420.12 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Carl Zeiss Meditec USA, INC. | $1,870.59 | 2023 | Veracity Surgical, Iolmaster 700, Cirrus Hd-Oct |
| Allergan, INC. | $1,515.22 | 2019-2022 | |
| Alcon Vision LLC | $1,304.00 | 2019-2025 | Rocklatan, Tryptyr, Argos |
| Abbvie INC. | $1,155.00 | 2022 | |
| Bausch & Lomb Americas INC. | $1,041.00 | 2022-2025 | Envista Mx60 Iol, Stellaris, Envista Aspire Iol |
| Lumenis Be INC | $958.53 | 2024 | Optilight |
| New World Medical,INC. | $583.33 | 2022-2023 | |
| Rxsight INC | $548.85 | 2022-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Novartis Pharmaceuticals Corporation | $455.16 | 2019-2023 | |
| Kala Pharmaceuticals, INC. | $386.28 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $305.19 | 2019-2025 | |
| Apellis Pharmaceuticals, INC. | $295.59 | 2022-2024 | Syfovre |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $189.95 | 2021-2024 | |
| Aerie Pharmaceuticals, INC. | $150.86 | 2019-2021 | |
| Ocular Therapeutix, INC. | $139.91 | 2024 | Dextenza |
| Revance Therapeutics, INC. | $132.50 | 2024-2025 | Daxxify |
| Genentech USA, INC. | $98.46 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $96.65 | 2019-2021 | |
| Oyster Point Pharma, INC. | $56.51 | 2022 | |
| Eyepoint US, INC. | $52.25 | 2019 | |
| Eyevance Pharmaceuticals LLC | $41.88 | 2019-2022 | |
| Omeros Corporation | $32.53 | 2019 | |
| Janssen Pharmaceuticals, INC | $28.01 | 2019-2021 | |
| Shire North American Group INC | $26.11 | 2019 | |
| Rayner Intraocular Lenses Limited | $13.23 | 2022 | |
| Beaver-Visitec International, INC. | $12.37 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Gershenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.